Novel N-acyl-(3-substituted)-5,6, 7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders

摘要

The present invention relates to novel compounds of Formula I, and their use in therapeutic treatments.